Bruce A Littlefield
Inventor
Stats
- 8 US patents issued
- 19 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 8 US Patents Issued
- 19 US Applications Filed
- 190 Total Citation Count
- Jul 23, 2018 Most Recent Filing
- May 1, 1992 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| EISAI CO., LTD. | 1
| 2005
|
| EISAI R&D MANAGEMENT CO., LTD. | 1
1 1 1 1 2 1 4 1 1 1 2 | 1992
1999 2000 2001 2002 2003 2004 2005 2009 2010 2012 2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| Andover, MA | Aug 23, 94 - Dec 30, 08 |
| Andover, MA, US | Oct 07, 04 - Apr 30, 20 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 14 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2020/0129,473 | 2020 | USE OF ERIBULIN AND CYCLIN DEPENDENT KINASE INHIBITORS IN THE TREATMENT OF CANCER | 0 |
| 2019/0282,541 | 2019 | USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER | 1 |
| 9637795 | 2017 | Methods and compositions for predicting response to eribulin | 0 |
| 2017/0100,367 | 2017 | USE OF ERIBULIN IN THE TREATMENT OF CANCER | 1 |
| 2017/0071,903 | 2017 | USE OF ERIBULIN AND MTOR INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER | 6 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.